Medworld器械世界为您提供准确、及时、有效的医疗器械行业及医疗圈的市场动态,产品信息,技术进展等资讯来源: COVID-19 of MDDIIn response to healthcare workers asking for safer ways to monitor hospitalized diabetes patients with COVID-19, FDA is allowing both Dexcom and Abbott to supply continuous glucose monitoring (CGM) systems for use in the hospital setting during the pandemic. This allows frontline healthcare workers in hospitals to remotely monitor patients with diabetes in order to minimize exposure to the virus that causes COVID-19 and preserve use of personal protective equipment (PPE).Abbott said it has partnered with the American Diabetes Association, Insulin for Life USA, and the Diabetes Disaster Response Coalition to donate 25,000 FreeStyle Libre 14-day sensors to U.S. hospitals and medical centers in outbreak hotspots t
………………………………